Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Protara Therapeutics, Inc. | f10k_031820p.htm |
| EX-32.1 - EXHIBIT 32.1 - Protara Therapeutics, Inc. | exh_321.htm |
| EX-31.2 - EXHIBIT 31.2 - Protara Therapeutics, Inc. | exh_312.htm |
| EX-31.1 - EXHIBIT 31.1 - Protara Therapeutics, Inc. | exh_311.htm |
| EX-23.1 - EXHIBIT 23.1 - Protara Therapeutics, Inc. | exh_231.htm |
| EX-10.36 - EXHIBIT 10.36 - Protara Therapeutics, Inc. | exh_1036.htm |
| EX-10.30 - EXHIBIT 10.30 - Protara Therapeutics, Inc. | exh_1030.htm |
| EX-10.29 - EXHIBIT 10.29 - Protara Therapeutics, Inc. | exh_1029.htm |
| EX-10.25 - EXHIBIT 10.25 - Protara Therapeutics, Inc. | exh_1025.htm |
| EX-4.3 - EXHIBIT 4.3 - Protara Therapeutics, Inc. | exh_43.htm |
Exhibit 21.1
List of Subsidiaries
| Name of Subsidiary | Jurisdiction |
| Proteon Therapeutics Limited | United Kingdom |
| Proteon Securities Corp. | Massachusetts |
| Proteon International Holdings, Inc. | Delaware |
| Proteon Bermuda Limited | Bermuda |
| Proteon Ireland Limited Ireland | Ireland |
| ArTara Subsidiary, Inc. | Delaware |
All subsidiaries are 100% owned.